N2 Jenomics Lab Pvt. Ltd. provides Single-Cell ATAC-seq Service for researchers who need to study chromatin accessibility at cell-type resolution. We help you evaluate cell or nuclei input, build sequencing-ready chromatin accessibility libraries, and turn sparse single-cell epigenomic data into clusters, peaks, motifs, gene activity outputs, and regulatory interpretation.
Single-cell ATAC-seq, also known as scATAC-seq, profiles chromatin accessibility across individual cells or nuclei. Instead of averaging signals across a mixed sample, it helps separate regulatory patterns by cell type, cell state, treatment group, or differentiation stage.
This matters when bulk ATAC-seq is too averaged to explain a heterogeneous sample. In tumors, immune tissues, organoids, developmental systems, or disease models, different cell populations may carry different accessible enhancers, promoters, and transcription factor motifs. scATAC-seq helps reveal those differences at single-cell resolution.
We use this service to help research teams move from "which genes are expressed?" to "which regulatory regions may be active in specific cell populations?" The result is not only a sequencing dataset, but a regulatory view that can support mechanism-focused research.
scATAC-seq identifies regions of open chromatin where transposase-accessible DNA can be captured and sequenced. These regions often include promoters, enhancers, and other regulatory elements that help define cell identity or cell-state transitions.
These outputs are especially useful when your project needs regulatory evidence beyond transcript abundance.

scRNA-seq is powerful for gene expression and cell identity analysis, but it does not directly measure whether regulatory DNA is accessible. scATAC-seq fills that gap by showing where chromatin is open in different cell populations.
For expression-focused projects, you can review our Single-cell RNA Sequencing service. For broader single-cell project planning, see our Single-Cell Sequencing platform.
| Research Area | How scATAC-seq Helps |
|---|---|
| Oncology | Resolves tumor, stromal, and immune regulatory programs at cell-type level. |
| Immunology | Profiles chromatin accessibility during immune activation, differentiation, or inflammation. |
| Stem cell research | Tracks regulatory changes during lineage commitment and cell fate transition. |
| Developmental biology | Helps identify accessible regulatory elements across developmental stages. |
| Organoid models | Compares differentiation states and regulatory heterogeneity in model systems. |
| Neuroscience | Supports cell-type-specific regulatory studies in complex neural tissues. |
| Drug response research | Identifies regulatory shifts associated with treatment or perturbation. |
Our scATAC-seq workflow follows your sample from project intake to regulatory interpretation. We review sample quality, transposition behavior, library performance, sequencing output, and data QC before treating the results as biological evidence.
A typical project includes sample feasibility review, cell or nuclei input assessment, Tn5 transposition, single-cell barcoding, library construction, sequencing, data QC, and bioinformatics analysis.

We begin with your sample and the regulatory question you want to answer. Our team reviews sample type, species, tissue source, preservation method, expected cell or nuclei input, biological groups, and downstream analysis goals.
This review helps us decide whether scATAC-seq is a suitable workflow and which preparation details should be addressed before sample submission.
scATAC-seq commonly uses nuclei as input because chromatin accessibility is measured through transposase access to nuclear DNA. If you already have cells or nuclei prepared, we review input quality before library preparation. If your project starts from tissue, we first consider whether nuclei can be recovered in a condition suitable for transposition.
Poor input quality can reduce useful fragments, weaken TSS enrichment, increase background signal, and make clustering or annotation more difficult.
In scATAC-seq, accessible chromatin regions are tagged by Tn5 transposase. These accessible DNA fragments are then linked to single-cell or single-nucleus barcodes, allowing reads to be assigned back to individual cells or nuclei.
This workflow allows chromatin accessibility to be studied at the single-cell level rather than as an average signal across the whole sample.
After barcoding and library construction, we review library performance and sequencing data quality before moving into biological interpretation.
These QC layers help determine whether the dataset is suitable for clustering, peak calling, motif analysis, and condition comparison.
Once the data pass QC review, we move into regulatory analysis. This includes alignment or fragment processing, peak calling, construction of a cell-by-peak accessibility matrix, clustering, dimensionality reduction, marker peak identification, annotation support, motif enrichment, and optional integration.
The goal is to provide outputs that your team can inspect, question, reuse, and connect to the next experiment.
Sample preparation is one of the most important factors in scATAC-seq data quality. The values below are practical references for planning. Final requirements may vary by species, tissue type, sample condition, platform choice, and project design.
| Sample Type | Recommended Input | Quality Requirements | Shipping / Storage | Key QC Checkpoints | Notes |
|---|---|---|---|---|---|
| Cell suspension | >1×105 cells as a reference | >80% viability; 500–1,000 cells/µL; <5% aggregation; no fragments >40 µm | Cold-chain or project-dependent handling | Viability, debris, aggregation, inhibitors | Suitable for high-quality dissociated cells. |
| Nuclei suspension | Project-dependent; review before submission | Intact nuclei, low debris, low clumping | Cold-chain as advised | Nuclei integrity, concentration, singlets | Preferred input for many scATAC-seq workflows. |
| Blood or immune cell samples | >5 mL whole blood in EDTA tube as a reference | No heparin anticoagulant | Fresh shipment as advised | Cell recovery and immune subset preservation | Useful for PBMC or immune-cell projects. |
| Fresh tissue | 0.3 cm × 0.3 cm, 4–5 pieces as a reference | Avoid large tissue blocks | Cold-chain coordination | Tissue integrity and nuclei release | Requires feasibility review before project setup. |
| Frozen tissue | Project-dependent | Avoid repeated freeze-thaw | Dry ice or frozen condition | Nuclei release, debris, chromatin integrity | Requires review before project setup. |
| Sorted subsets | Project-dependent | Low debris and sufficient cells or nuclei | As advised | Recovery, concentration, viability or nuclei integrity | Useful for rare populations or targeted cell subsets. |
For broader submission guidance, please review our Sample Submission Guidelines.
A scATAC-seq project should not stop at read alignment or peak calling. You need to know whether the data can support clustering, which cell populations carry specific accessibility patterns, and which regulatory elements or motifs may explain biological differences.
N2 Jenomics Lab Pvt. Ltd. connects QC metrics, accessibility peaks, cell clustering, motif enrichment, gene activity, and optional transcriptomic integration in one analysis workflow.
| Deliverable | What You Receive | Why It Matters |
|---|---|---|
| Raw sequencing data | FASTQ files | Enables data archiving and future reprocessing. |
| Alignment output | BAM or aligned fragments when applicable | Supports review of mapped chromatin fragments. |
| Fragment file | Barcode-linked chromatin fragments | Core input for downstream scATAC-seq analysis. |
| Cell calling summary | Retained cell or nuclei barcode summary | Helps evaluate usable cell recovery. |
| Cell-by-peak matrix | Accessibility matrix across cells and peaks | Forms the basis for clustering and comparison. |
| Peak set and peak annotation | Accessible regions with genomic annotation | Supports regulatory element interpretation. |
| QC summary | Library, sequencing, and cell-level QC metrics | Helps judge whether the dataset supports analysis. |
| Fragment size distribution | Nucleosome-related fragment pattern review | Supports library quality assessment. |
| TSS enrichment summary | Enrichment near transcription start sites | Common signal-quality indicator for ATAC data. |
| Dimensionality reduction plots | UMAP or t-SNE views | Shows cell-level accessibility structure. |
| Clustering results | Cluster assignments and metadata | Supports cell population discovery. |
| Marker peak table | Cluster-associated accessible regions | Helps define regulatory differences by group. |
| Cell type annotation support | Annotation based on accessibility and optional references | Connects clusters to biological meaning. |
| Analysis report | Methods, figures, tables, and notes | Gives your team a readable project summary. |

Many researchers use scATAC-seq after scRNA-seq has identified important cell populations. In that setting, scATAC-seq helps explain the regulatory layer behind gene expression changes.
When expression and accessibility need to be measured in the same cell, a single-cell multiome strategy may be more appropriate. When the chromatin accessibility layer is the main question, standalone scATAC-seq can be a focused and efficient option.
We do not treat single-cell epigenomics analysis as a black box. When applicable, we can provide reusable files and analysis notes so your internal bioinformatics team can review the workflow.
The right epigenomic or transcriptomic method depends on your biological question. We help you choose the option that fits your sample, required resolution, and interpretation goals.
| Method | Molecular Layer | Best-Fit Sample | Resolution | Strength | Limitation | When to Choose |
|---|---|---|---|---|---|---|
| scATAC-seq | Chromatin accessibility | Cells or nuclei | Single-cell | Resolves cell-type-specific regulatory elements | Sparse data; needs careful analysis | Choose this when cell-type-specific chromatin accessibility is the key question. |
| Bulk ATAC-seq | Chromatin accessibility | Tissue or cell population | Bulk sample average | Simpler workflow and lower analysis complexity | Masks cell-type-specific signals | Choose this when sample-average accessibility is sufficient. |
| scRNA-seq | Gene expression | Viable cells or nuclei depending on workflow | Single-cell or single-nucleus | Defines cell identity and expression states | Does not directly measure chromatin accessibility | Choose this when gene expression and cell-state mapping are the main focus. |
| Single-cell multiome | ATAC + gene expression | High-quality cells or nuclei | Same-cell multi-layer | Links accessibility and expression directly | Higher complexity and stricter sample needs | Choose this when same-cell accessibility and expression are both required. |
| CUT&Tag / ChIP-seq | Protein-DNA binding or histone mark enrichment | Cells or tissue, depending on method | Bulk or low-input depending on workflow | Target-specific TF or histone mark profiling | Requires target-specific antibody | Choose this when a specific chromatin protein, TF, or histone mark is the focus. |
Choose scATAC-seq when your main question is cell-type-specific chromatin accessibility.
Choose bulk ATAC-seq when you need a sample-average accessibility screen and do not need to separate signals by cell population.
Choose scRNA-seq when cell identity, gene expression, and transcriptomic states are the primary focus.
Choose single-cell multiome when accessibility and expression must be measured in the same cell.
Choose CUT&Tag or ChIP-seq when your study focuses on a specific transcription factor, histone mark, or chromatin-associated protein.
Combine methods when regulatory interpretation requires more than one evidence layer. For immune-focused projects, you may also explore our scTCR/BCR-seq Service. For nuclei-based transcriptomic profiling, see our snRNA-seq Service.
A successful scATAC-seq project requires more than library construction and sequencing. It needs sample judgment, chromatin-accessibility-specific QC, careful data processing, and regulatory analysis that your team can understand and reuse.

References
For Research Use Only (RUO). This service is not intended for clinical diagnosis, medical interpretation, patient management, treatment guidance, or Direct-to-Consumer genetic testing.
Demo results help you preview the kinds of outputs a scATAC-seq project can generate. The exact figures depend on sample quality, study design, organism, and analysis scope, but the result categories below are common in regulatory interpretation projects.
![]() Cell Clustering and Accessibility-Based Annotation A UMAP or t-SNE plot can show how cells or nuclei cluster based on chromatin accessibility patterns. Clusters may be annotated using accessibility patterns, marker peaks, gene activity scores, reference datasets, or integration with expression data. Typical visual: UMAP colored by chromatin accessibility clusters and annotated cell types. How we use it: To identify cell populations and organize downstream peak and motif analysis. | ![]() Peak Tracks and Regulatory Element Views Genome browser-style peak tracks can show accessibility signals across cell clusters, sample groups, or selected genomic regions. These views are useful when researchers want to examine promoters, enhancers, or regions near genes of interest. Typical visual: Peak tracks across clusters or conditions near representative loci. How we use it: To connect regulatory regions with cell types, genes, or experimental groups. | ![]() Motif Enrichment and RNA/ATAC Integration Motif enrichment analysis can identify transcription factor binding motifs enriched in accessible regions. When scRNA-seq data are available, integration can help connect accessibility with expression and cell identity. Typical visual: Motif enrichment heatmap plus gene activity or RNA/ATAC integration panel. How we use it: To prioritize transcription factors, regulatory programs, and follow-up hypotheses. |
For Research Use Only (RUO). This service is not intended for clinical diagnosis, medical interpretation, patient management, treatment guidance, or Direct-to-Consumer genetic testing.
Source: Semi-automated IT-scATAC-seq profiles cell-specific chromatin accessibility in differentiation and peripheral blood populations
Background
Single-cell ATAC-seq is valuable for mapping chromatin accessibility at cell-level resolution, but method performance depends on nuclei handling, library complexity, indexing strategy, QC metrics, and analysis workflow. For studies of differentiation or mixed cell populations, these factors determine whether accessibility profiles can be interpreted as meaningful regulatory signals.
The 2025 Nature Communications study introduced a semi-automated indexed Tn5-based scATAC-seq workflow designed to profile cell-specific chromatin accessibility in differentiation systems and peripheral blood populations.
Methods
The study used indexed Tn5 tagmentation and a three-round barcoding strategy. Nuclei were isolated, transposed with indexed Tn5 complexes, sorted into 384-well plates, amplified with indexed PCR, sequenced, and analyzed for chromatin accessibility profiles.
The authors evaluated workflow performance using species-mixing experiments, replicate comparisons, TSS enrichment, nucleosome periodicity, UMAP clustering, cell population separation, motif enrichment, and differentiation-related regulatory changes.
Results
In Figure 1, the authors presented the IT-scATAC-seq workflow and benchmark. The study reported species-mixing accuracy of 98.72%, replicate correlation above 0.97, strong TSS enrichment, nucleosome periodicity, and UMAP-based separation of cell populations.

The paper also evaluated mouse embryonic stem cell differentiation. In the differentiation analysis, the authors reported 4,167 QC-passed cells, 131.81 million fragments, median TSS enrichment of 14.35, and median FRiP of 0.69. These results supported the method's ability to capture cell-specific chromatin accessibility during early differentiation.
Conclusion
This case illustrates why a scATAC-seq service needs more than sequencing capacity. Meaningful regulatory interpretation depends on nuclei handling, transposition quality, library complexity, QC metrics, clustering, accessible peaks, and motif analysis. For research teams, these QC and analysis layers are essential for turning chromatin accessibility data into interpretable regulatory evidence.
For Research Use Only (RUO). This service is not intended for clinical diagnosis, medical interpretation, patient management, treatment guidance, or Direct-to-Consumer genetic testing.
What does scATAC-seq measure?
scATAC-seq measures chromatin accessibility at single-cell or single-nucleus resolution. It identifies regions of open chromatin that may include promoters, enhancers, and other regulatory elements.
How is scATAC-seq different from bulk ATAC-seq?
Bulk ATAC-seq measures average chromatin accessibility across a mixed sample. scATAC-seq separates accessibility patterns by individual cells or nuclei, making it better suited for heterogeneous tissues or mixed cell populations.
When should I choose scATAC-seq instead of scRNA-seq?
Choose scATAC-seq when your main question is about chromatin accessibility, regulatory elements, transcription factor motifs, or regulatory programs. Choose scRNA-seq when your main question is gene expression and cell-state mapping. Many projects benefit from using both.
What sample types can be used for scATAC-seq?
scATAC-seq projects may use high-quality cell suspensions, nuclei suspensions, blood or immune-cell samples, fresh tissue, frozen tissue, organoids, or sorted cell populations. Feasibility depends on sample quality, debris level, concentration, and nuclei or cell integrity.
What QC metrics matter most for scATAC-seq?
Important QC metrics may include cell or nuclei recovery, library complexity, fragment size distribution, unique fragments per cell, TSS enrichment, FRiP or peak-related metrics, barcode recovery, and peak quality.
What files and analysis outputs will I receive?
Typical deliverables include raw sequencing files, fragment files, peak sets, accessibility matrices, QC summaries, UMAP or t-SNE plots, clustering results, marker peak tables, motif enrichment results, annotation support, figure files, and an analysis report.
Can N2 Jenomics Lab Pvt. Ltd. support motif enrichment and gene activity analysis?
Yes. We can support motif enrichment, transcription factor activity inference, gene activity score calculation, peak-to-gene linkage, and differential accessibility analysis depending on your project design.
Can scATAC-seq be integrated with scRNA-seq?
Yes. Optional integration can support label transfer, joint embedding, gene activity comparison, and regulatory interpretation across chromatin accessibility and gene expression data.
Is scATAC-seq suitable for frozen tissue or nuclei input?
scATAC-seq can be compatible with nuclei-based workflows, but frozen tissue and nuclei input should be reviewed before project setup. Nuclei integrity, debris, clumping, and chromatin quality are key considerations.
What should I provide before requesting a project review?
Please provide sample type, species, tissue source, preservation method, expected cell or nuclei input, number of groups, replicate design, and the main regulatory question you want to answer.
For Research Use Only (RUO). This service is not intended for clinical diagnosis, medical interpretation, patient management, treatment guidance, or Direct-to-Consumer genetic testing.